|  | | | Reviews | Top |  | Intestinal tuft cells: epithelial sentinels linking luminal cues to the immune systemF Gerbe and P Jay Mucosal Immunol. 2016 9: 1353-1359; advance online publication, August 24, 2016; 10.1038/mi.2016.68 Abstract | Full Text |  |  |  | Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grailB Pigneur and H Sokol Mucosal Immunol. 2016 9: 1360-1365; advance online publication, July 27, 2016; 10.1038/mi.2016.67 Abstract | Full Text |  | Commentary | Top |  | A double edged sword: Schistosoma mansoni Sm29 regulates both Th1 and Th2 responses in inflammatory mucosal diseasesSergio C Oliveira, Barbara C Figueiredo, Luciana S Cardoso and Edgar M Carvalho Mucosal Immunol. 2016 9: 1366-1371; advance online publication, August 24, 2016; 10.1038/mi.2016.69 Full Text |  | Articles | Top |  | INNATE IMMUNITY AND INFLAMMATION | Group 3 innate lymphoid cells regulate neutrophil migration and function in human deciduaD Croxatto, A Micheletti, E Montaldo, P Orecchia, F Loiacono, F Canegallo, F Calzetti, E Fulcheri, E Munari, A Zamò, P L Venturini, L Moretta, M A Cassatella, M C Mingari and P Vacca Mucosal Immunol. 2016 9: 1372-1383; advance online publication, February 24, 2016; 10.1038/mi.2016.10 Abstract | Full Text |  |  |  | ADAPTIVE IMMUNITY | IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cellsT Mchedlidze, M Kindermann, A T Neves, D Voehringer, M F Neurath and S Wirtz Mucosal Immunol. 2016 9: 1384-1394; advance online publication, March 16, 2016; 10.1038/mi.2016.20 Abstract | Full Text |  |  |  | Regulatory T cells are essential to promote proper CD4 T-cell priming upon mucosal infectionA G Soerens, A Da Costa and J M Lund Mucosal Immunol. 2016 9: 1395-1406; advance online publication, March 23, 2016; 10.1038/mi.2016.19 Abstract | Full Text |  |  |  | IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection OPENV S Pelly, Y Kannan, S M Coomes, L J Entwistle, D Rückerl, B Seddon, A S MacDonald, A McKenzie and M S Wilson Mucosal Immunol. 2016 9: 1407-1417; advance online publication, February 17, 2016; 10.1038/mi.2016.4 Abstract | Full Text |  |  |  | BARRIER FUNCTION AND EPITHELIAL CELL BIOLOGY | Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammationS Banerjee, G Sindberg, F Wang, J Meng, U Sharma, L Zhang, P Dauer, C Chen, J Dalluge, T Johnson and S Roy Mucosal Immunol. 2016 9: 1418-1428; advance online publication, February 24, 2016; 10.1038/mi.2016.9 Abstract | Full Text |  |  |  | Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa OPENM E Mulcahy, J M Leech, J-C Renauld, K HG Mills and R M McLoughlin Mucosal Immunol. 2016 9: 1429-1441; advance online publication, March 23, 2016; 10.1038/mi.2016.24 Abstract | Full Text |  |  |  | The innate immune properties of airway mucosal surfaces are regulated by dynamic interactions between mucins and interacting proteins: the mucin interactome OPENG Radicioni, R Cao, J Carpenter, A A Ford, T T Wang, Y Li and M Kesimer Mucosal Immunol. 2016 9: 1442-1454; advance online publication, April 13, 2016; 10.1038/mi.2016.27 Abstract | Full Text |  |  |  | MICROBIOME | Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activationS F Jørgensen, M Trøseid, M Kummen, J A Anmarkrud, A E Michelsen, L T Osnes, K Holm, M L Høivik, A Rashidi, C P Dahl, M Vesterhus, B Halvorsen, T E Mollnes, R K Berge, B Moum, K E A Lundin, B Fevang, T Ueland, T H Karlsen, P Aukrust and J R Hov Mucosal Immunol. 2016 9: 1455-1465; advance online publication, March 16, 2016; 10.1038/mi.2016.18 Abstract | Full Text |  |  |  | ALLERGIC INFLAMMATION AND DISEASE | Mast cell-derived neurotrophin 4 mediates allergen-induced airway hyperinnervation in early life OPENK R Patel, L Aven, F Shao, N Krishnamoorthy, M G Duvall, B D Levy and X Ai Mucosal Immunol. 2016 9: 1466-1476; advance online publication, February 10, 2016; 10.1038/mi.2016.11 Abstract | Full Text |  |  |  | The mycotoxin deoxynivalenol facilitates allergic sensitization to whey in miceM Bol-Schoenmakers, S Braber, P Akbari, P de Graaff, M van Roest, L Kruijssen, J J Smit, B C A M van Esch, P V Jeurink, J Garssen, J Fink-Gremmels and R H H Pieters Mucosal Immunol. 2016 9: 1477-1486; advance online publication, February 17, 2016; 10.1038/mi.2016.13 Abstract | Full Text |  |  |  | AUTOIMMUNITY, INFLAMMATORY BOWEL DISEASE, AND CANCER | T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitisJ Zimmermann, A A Kühl, M Weber, J R Grün, J Löffler, C Haftmann, R Riedel, P Maschmeyer, K Lehmann, K Westendorf, M-F Mashreghi, M Löhning, M Mack, A Radbruch and H D Chang Mucosal Immunol. 2016 9: 1487-1499; advance online publication, February 17, 2016; 10.1038/mi.2016.5 Abstract | Full Text |  |  |  | Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 productionM Khalil, A Babes, R Lakra, S Försch, P W Reeh, S Wirtz, C Becker, M F Neurath and M A Engel Mucosal Immunol. 2016 9: 1500-1513; advance online publication, March 16, 2016; 10.1038/mi.2016.16 Abstract | Full Text |  |  |  | CD45 regulates GM-CSF, retinoic acid and T-cell homing in intestinal inflammationA Samarakoon, Y A Shim, M Dosanjh, M Crickmer, C Labonté-Raymond, A A Arif and P Johnson Mucosal Immunol. 2016 9: 1514-1527; advance online publication, March 23, 2016; 10.1038/mi.2016.23 Abstract | Full Text |  |  |  | INFECTIOUS DISEASES AND HOST DEFENSE | Prevention of SHIV transmission by topical IFN-β treatmentR S Veazey, H A Pilch-Cooper, T J Hope, G Alter, A M Carias, M Sips, X Wang, B Rodriguez, S F Sieg, A Reich, P Wilkinson, M J Cameron and M M Lederman Mucosal Immunol. 2016 9: 1528-1536; advance online publication, February 3, 2016; 10.1038/mi.2015.146 Abstract | Full Text |  |  |  | Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriageA L Cole, G Muthukrishnan, C Chong, A Beavis, C R Eade, M P Wood, M G Deichen and A M Cole Mucosal Immunol. 2016 9: 1537-1548; advance online publication, February 3, 2016; 10.1038/mi.2016.2 Abstract | Full Text |  |  |  | Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16B M Gunn, J R Schneider, M Shansab, A R Bastian, K M Fahrbach, A D Smith, IV, A E Mahan, M M Karim, A F Licht, I Zvonar, J Tedesco, M R Anderson, A Chapel, T J Suscovich, D C Malaspina, H Streeck, B D Walker, A Kim, G Lauer, M Altfeld, S Pillai, I Szleifer, N L Kelleher, P F Kiser, T J Hope and G Alter Mucosal Immunol. 2016 9: 1549-1558; advance online publication, March 9, 2016; 10.1038/mi.2016.8 Abstract | Full Text |  |  |  | Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infectionS Zhu, M K Jones, D Hickman, S Han, W Reeves and S M Karst Mucosal Immunol. 2016 9: 1559-1570; advance online publication, March 23, 2016; 10.1038/mi.2016.15 Abstract | Full Text |  |  |  | Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infectionN E Quispe Calla, R D Vicetti Miguel, P N Boyaka, L Hall-Stoodley, B Kaur, W Trout, S D Pavelko and T L Cherpes Mucosal Immunol. 2016 9: 1571-1583; advance online publication, March 23, 2016; 10.1038/mi.2016.22 Abstract | Full Text |  |  |  | VACCINES | Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategiesM Sips, M Krykbaeva, T J Diefenbach, M Ghebremichael, B A Bowman, A-S Dugast, A W Boesch, H Streeck, D S Kwon, M E Ackerman, T J Suscovich, P Brouckaert, T W Schacker and G Alter Mucosal Immunol. 2016 9: 1584-1595; advance online publication, February 17, 2016; 10.1038/mi.2016.12 Abstract | Full Text |  |  |  | Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Mucosal Immunology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment